Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Market Update

Julia Lee
March 31, 2017

Market Update

Julia Lee
March 30, 2017

March Overview

Julia Lee
March 28, 2017

Market Update

Julia Lee
March 27, 2017

Market Update

Julia Lee
March 23, 2017

Market Update

Julia Lee
March 22, 2017

Market Update

Julia Lee
March 20, 2017

Market Update

Julia Lee
March 17, 2017

Market Update

Julia Lee
March 16, 2017

Market Update 15 March 2017

Julia Lee
March 15, 2017

How to review your portfolio

Bell Direct
March 14, 2017